Microbiological challenge of four protective devices for the reconstitution of cytotoxic agents

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Letters in Applied Microbiology

• Publication date

  2008-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1472-765X.2008.02463.xPMID 19120923
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enumeration of airborne bacteria and fungi using solid phase cytometry.

  2008cited by this paper
• Comparative contamination study with cyclophosphamide, fluorouracil and ifosfamide: standard technique versus a proprietary closed-handling system

  2004cited by this paper
• A randomized, prospective clinical trial to assess the potential infection risk associated with the PosiFlow needleless connector.

  2003cited by this paper
• Determining Sources of Workplace Contamination with Antineoplastic Drugs and Comparing Conventional IV Drug Preparation with a Closed System

  2003cited by this paper
• A needleless closed system device (CLAVE) protects from intravascular catheter tip and hub colonization: a prospective randomized study.

  2003cited by this paper
• Using a closed-system protective device to reduce personnel exposure to antineoplastic agents.

  2003cited by this paper
• Needleless connectors--the way forward in the prevention of catheter-related infections?

  2002cited by this paper
• Effectiveness of a closed-system device in containing surface contamination with cyclophosphamide and ifosfamide in an i.v. admixture area.

  2002cited by this paper
• How to protect environment and employees against cytotoxic agents, the UZ Ghent experience

  2000cited by this paper
• Surface contamination with antineoplastic agents in six cancer treatment centers in Canada and the United States.

  1999cited by this paper
• Evaluation of the PhaSeal Hazardous Drug Containment System

  1999cited by this paper
• Multiple Comparisons: Theory and Methods

  1997cited by this paper
• The potential for catheter microbial contamination from a needleless connector.

  1997cited by this paper

• Evaluation of long-term prevention of microbiological contamination of sterile preparations in a controlled ISO class 5 environment and an uncontrolled environment using a closed-system drug transfer device

  2025cites this paper
• Evaluating drug stability and sterility in single-dose vials when accessed with a closed system transfer device

  2024cites this paper
• Assessment of environmental viral contamination of liquids prepared in a closed system drug transfer device

  2024cites this paper
• Use of Closed System Transfer Devices (CSTDs) with Protein-Based Therapeutic Drugs - a Non-Solution for a Non-Problem?

  2023cites this paper
• Integrity performance assessment of a closed system transfer device syringe adaptor lock as a terminal closure for Luer-Lock syringes

  2022cites this paper
• Closed-system transfer device use with oncology biologics: A survey of Canadian healthcare practitioners

  2021cites this paper
• Integrity performance assessment of a Closed System Transfer Device syringe adaptor as a terminal closure for Luer-Lock syringes.

  2021cites this paper
• Advanced Medical Devices for Preparation and Administration of Chemotherapeutic Agents: Results from a Multi-Dimensional Evaluation

  2020cites this paper
• Review of economic data on closed system transfer drug for preparation and administration of hazardous drugs

  2019cites this paper
• Sterility Duration of Single-Use Vials for Antineoplastic Agents or Monoclonal Antibodies Extended with a Closed-System Transfer Device

  2019cites this paper
• Review of studies examining microbial contamination of vials used for preparations done with closed-system drug transfer devices

  2019cites this paper
• How can the use of closed system transfer devices to facilitate sharing of drug vials be optimised to achieve maximum cost savings?

  2019cites this paper
• Sistemas de seguridad en la preparación de medicamentos peligrosos

  2019cites this paper
• Utility of PhaSeal, a closed‐system drug transfer device, in facilitating vial sharing to reduce waste and assist in medication cost savings

  2019cites this paper
• Closed-system drug-transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff.

  2018cites this paper
• BD PhaSeal™ and particulate contamination

  2018cites this paper
• A literature review of reports of the stability and storage of common injectable chemotherapy agents used in veterinary patients.

  2017cites this paper
• Cost Analysis of Using a Closed-System Transfer Device (CSTD) for Antineoplastic Drug preparation in a Malaysian Government-Funded Hospital

  2016cites this paper
• Determination of Extended Sterility for Single-Use Vials Using the PhaSeal Closed-System Transfer Device

  2016cites this paper
• Responding to drug shortages and rising costs: IV chemotherapy drug use optimization achieved by closed safety devices in hospital pharmacies

  2016cites this paper
• Responding to drug shortages and rising costs: IV chemotherapy drug use optimization achieved by closed safety devices in hospital pharmacies

  2016cites this paper
• Closed systems for drug delivery: a necessity, not an option.

  2015cites this paper
• Economic evaluation of a closed-system drug transfer device for the preparation of IV ganciclovir within care units

  2015cites this paper
• Potential cost savings associated with dose rounding antineoplastic monoclonal agents

  2015cites this paper
• Sistemas cerrados de transferencia de fármacos

  2014cites this paper
• Effectiveness of a closed system device in reducing occupational exposure and environmental concentrations of anticancer drugs

  2014cites this paper
• Occupational exposure to anti-cancer drugs: A review of effects of new technology

  2014cites this paper
• Aseptic simulation test for cytotoxic drug production in isolators.

  2014cites this paper
• Microbiological Challenge Test of Contamination Caused by Using the PhaSeal System

  2013cites this paper
• Cost savings realized by use of the PhaSeal® closed-system transfer device for preparation of antineoplastic agents

  2013cites this paper
• A summary of the published clinical evidence of the effectiveness of the BD PhaSeal closed-system drug transfer device (CSTD)

  2013cites this paper
• Economic and microbiologic evaluation of single-dose vial extension for hazardous drugs.

  2012cites this paper
• Comparaison des dispositifs scuriss de prparation des cytotoxiques

  2011cites this paper
• Comparative parallel assessment of a transfer device in reducing 5-fluorouracil environmental contamination inside positive air pressure isolators

  2011cites this paper
• Utility of the PhaSeal Closed System Drug Transfer Device

  2011cites this paper